[Cancer immunotherapy: new approaches]

Datopotamab deruxtecan in patients with untreated, advanced triple-negative breast cancer (TROPION-Breast02): a randomised, open-label, international, phase III trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Artificial intelligence in medicine: a scoping review of the risk of deskilling and loss of expertise among physicians.

ESMO real world data and digital oncology·2026

Prediction of Mutations and Outcome in Gastrointestinal Stromal Tumors with Deep Learning: A Multicenter, Multinational Study.

medRxiv : the preprint server for health sciences·2026

Transforming breast cancer management with real-world data and artificial intelligence.

ESMO real world data and digital oncology·2026

Pathological complete response with neoadjuvant pembrolizumab and chemotherapy in non-metastatic triple-negative inflammatory breast cancer.

ESMO open·2026

Extended Lombardy's Neonatal Screening Dataset.

Scientific data·2025

[Admission criteria to the intensive care unit for cancer patients: The perspective of the intensivist and the oncologist].

Bulletin du cancer·2026

[Burkitt lymphoma: Definition, diagnostic approach, and current therapeutic strategies].

Bulletin du cancer·2026

[How to prevent and manage PARP inhibitor-related hematological toxicities in prostate cancer?]

Bulletin du cancer·2026

[Specificity in the management of gynecological cancers in French overseas departments].

Bulletin du cancer·2026

Determinants of return to work in long-term metastatic breast cancer survivors: Results of a multicenter French cohort.

Bulletin du cancer·2026

[Anticipating intensive care decisions in oncology: Evolution of the use of the INFO REA tool at the Léon-Bérard Cancer Center (2020-2024)].

Bulletin du cancer·2026

Correction: An integrated automated deep learning framework for annotating tumor-infiltrating lymphocytes in lung adenocarcinoma pathology.

Frontiers in bioinformatics·2026

Development and pilot validation of a chemiluminescence immunoassay for monitoring immunologic changes during peanut oral immunotherapy using sIgE/sIgG4 ratio.

Frontiers in allergy·2026

Real-world outcomes of subcutaneous infliximab in a Middle Eastern inflammatory bowel disease cohort: a prospective study of switch and de novo treatment strategies.

Crohn's & colitis 360·2026

A pipeline for cell migration analysis in live-cell imaging data from human iPSC-derived forebrain assembloids.

Frontiers in cell and developmental biology·2026

Tislelizumab-induced myositis antibody-negative myasthenia gravis in patients with urothelial carcinoma: a case report.

Frontiers in immunology·2026

Case Report: Localized neutrophilic dermatosis at a split-skin donor site during PD-1 blockade: a unique immune-related adverse event.

Frontiers in immunology·2026

Related Experiment Videos

[Cancer immunotherapy: new approaches]

Related Concept Videos

Datopotamab deruxtecan in patients with untreated, advanced triple-negative breast cancer (TROPION-Breast02): a randomised, open-label, international, phase III trial.

Artificial intelligence in medicine: a scoping review of the risk of deskilling and loss of expertise among physicians.

Prediction of Mutations and Outcome in Gastrointestinal Stromal Tumors with Deep Learning: A Multicenter, Multinational Study.

Transforming breast cancer management with real-world data and artificial intelligence.

Pathological complete response with neoadjuvant pembrolizumab and chemotherapy in non-metastatic triple-negative inflammatory breast cancer.

Extended Lombardy's Neonatal Screening Dataset.

[Admission criteria to the intensive care unit for cancer patients: The perspective of the intensivist and the oncologist].

[Burkitt lymphoma: Definition, diagnostic approach, and current therapeutic strategies].

[How to prevent and manage PARP inhibitor-related hematological toxicities in prostate cancer?]

[Specificity in the management of gynecological cancers in French overseas departments].

Determinants of return to work in long-term metastatic breast cancer survivors: Results of a multicenter French cohort.

[Anticipating intensive care decisions in oncology: Evolution of the use of the INFO REA tool at the Léon-Bérard Cancer Center (2020-2024)].

Correction: An integrated automated deep learning framework for annotating tumor-infiltrating lymphocytes in lung adenocarcinoma pathology.

Development and pilot validation of a chemiluminescence immunoassay for monitoring immunologic changes during peanut oral immunotherapy using sIgE/sIgG4 ratio.

Real-world outcomes of subcutaneous infliximab in a Middle Eastern inflammatory bowel disease cohort: a prospective study of switch and de novo treatment strategies.

A pipeline for cell migration analysis in live-cell imaging data from human iPSC-derived forebrain assembloids.

Tislelizumab-induced myositis antibody-negative myasthenia gravis in patients with urothelial carcinoma: a case report.

Case Report: Localized neutrophilic dermatosis at a split-skin donor site during PD-1 blockade: a unique immune-related adverse event.

Related Experiment Videos

[Cancer immunotherapy: new approaches]

Related Concept Videos

Related Articles